Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample
Abstract Cognitive impairment occurs at higher rates in individuals at clinical high risk (CHR) for psychosis relative to healthy peers, and it contributes unique variance to multivariate prediction models of transition to psychosis. Such impairment is considered a core biomarker of schizophrenia. T...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Schizophrenia |
| Online Access: | https://doi.org/10.1038/s41537-025-00578-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849699608775622656 |
|---|---|
| author | Kelly Allott Walid Yassin Luis Alameda Tashrif Billah Owen Borders Kate Buccilli Ricardo E. Carrión Rolando I. Castillo-Passi Kang Ik K. Cho Kota Chin Michael J. Coleman Beau-Luke Colton Sebastián Corral Dominic Dwyer Kristina Ballestad Gundersen Ruben C. Gur Gil D. Hoftman Grace R. Jacobs Sinead Kelly Kathryn E. Lewandowski Patricia J. Marcy Priya Matneja Danielle McLaughlin Angela R. Nunez Setari Parsa Nora Penzel Susan Ray Jenna M. Reinen Kosha Ruparel Michael S. Sand Gennarina Santorelli Johanna Seitz-Holland Jessica Spark Zailyn Tamayo Andrew Thompson Sophie Tod Cassandra M. J. Wannan Alana Wickham Stephen J. Wood Eirini Zoupou Jean Addington Alan Anticevic Celso Arango Nicholas J. K. Breitborde Matthew R. Broome Kristin S. Cadenhead Monica E. Calkins Eric Yu Hai Chen Jimmy Choi Philippe Conus Cheryl M. Corcoran Barbara A. Cornblatt Lauren M. Ellman Paolo Fusar-Poli Pablo A. Gaspar Carla Gerber Louise Birkedal Glenthøj Leslie E. Horton Christy Lai Ming Hui Joseph Kambeitz Lana Kambeitz-Ilankovic Matcheri Keshavan Sung-Wan Kim Nikolaos Koutsouleris Jun Soo Kwon Kerstin Langbein Daniel Mamah Covadonga M. Diaz-Caneja Daniel H. Mathalon Vijay A. Mittal Merete Nordentoft Godfrey D. Pearlson Diana O. Perkins Jesus Perez Albert R. Powers Jack Rogers Fred W. Sabb Jason Schiffman Jai L. Shah Steven M. Silverstein Stefan Smesny Gregory P. Strauss Judy L. Thompson Rachel Upthegrove Swapna K. Verma Jijun Wang Daniel H. Wolf Ofer Pasternak Sylvain Bouix Patrick D. McGorry John M. Kane Rene S. Kahn Carrie E. Bearden Martha E. Shenton Scott W. Woods Barnaby Nelson Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) William S. Stone |
| author_facet | Kelly Allott Walid Yassin Luis Alameda Tashrif Billah Owen Borders Kate Buccilli Ricardo E. Carrión Rolando I. Castillo-Passi Kang Ik K. Cho Kota Chin Michael J. Coleman Beau-Luke Colton Sebastián Corral Dominic Dwyer Kristina Ballestad Gundersen Ruben C. Gur Gil D. Hoftman Grace R. Jacobs Sinead Kelly Kathryn E. Lewandowski Patricia J. Marcy Priya Matneja Danielle McLaughlin Angela R. Nunez Setari Parsa Nora Penzel Susan Ray Jenna M. Reinen Kosha Ruparel Michael S. Sand Gennarina Santorelli Johanna Seitz-Holland Jessica Spark Zailyn Tamayo Andrew Thompson Sophie Tod Cassandra M. J. Wannan Alana Wickham Stephen J. Wood Eirini Zoupou Jean Addington Alan Anticevic Celso Arango Nicholas J. K. Breitborde Matthew R. Broome Kristin S. Cadenhead Monica E. Calkins Eric Yu Hai Chen Jimmy Choi Philippe Conus Cheryl M. Corcoran Barbara A. Cornblatt Lauren M. Ellman Paolo Fusar-Poli Pablo A. Gaspar Carla Gerber Louise Birkedal Glenthøj Leslie E. Horton Christy Lai Ming Hui Joseph Kambeitz Lana Kambeitz-Ilankovic Matcheri Keshavan Sung-Wan Kim Nikolaos Koutsouleris Jun Soo Kwon Kerstin Langbein Daniel Mamah Covadonga M. Diaz-Caneja Daniel H. Mathalon Vijay A. Mittal Merete Nordentoft Godfrey D. Pearlson Diana O. Perkins Jesus Perez Albert R. Powers Jack Rogers Fred W. Sabb Jason Schiffman Jai L. Shah Steven M. Silverstein Stefan Smesny Gregory P. Strauss Judy L. Thompson Rachel Upthegrove Swapna K. Verma Jijun Wang Daniel H. Wolf Ofer Pasternak Sylvain Bouix Patrick D. McGorry John M. Kane Rene S. Kahn Carrie E. Bearden Martha E. Shenton Scott W. Woods Barnaby Nelson Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) William S. Stone |
| author_sort | Kelly Allott |
| collection | DOAJ |
| description | Abstract Cognitive impairment occurs at higher rates in individuals at clinical high risk (CHR) for psychosis relative to healthy peers, and it contributes unique variance to multivariate prediction models of transition to psychosis. Such impairment is considered a core biomarker of schizophrenia. Thus, cognition is a key domain measured in the Accelerating Medicines Partnership® program for Schizophrenia (AMP SCZ initiative). The aim of this paper is to describe the rationale, processes, considerations, and final harmonization of the cognitive battery used in AMP SCZ across the two data collection networks. This battery comprises tests of general intellect and specific cognitive domains. We estimate premorbid intelligence at baseline and measure current intelligence at baseline and 2 years. Eight tests from the Penn Computerized Neurocognitive Battery (PennCNB), which measure verbal learning and memory, sensorimotor ability, attention, emotion recognition, working memory, processing speed, verbal memory, visual memory, and motor speed are administered repeatedly at baseline, and four follow-up timepoints over 2 years. Watch Dr. Kelly Allott and Dr. William S. Stone discuss their work and this article: https://vimeo.com/1023396087 . |
| format | Article |
| id | doaj-art-e7e3cb12cc3d4550864f865dbb37edce |
| institution | DOAJ |
| issn | 2754-6993 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Schizophrenia |
| spelling | doaj-art-e7e3cb12cc3d4550864f865dbb37edce2025-08-20T03:18:32ZengNature PortfolioSchizophrenia2754-69932025-03-0111111210.1038/s41537-025-00578-1Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sampleKelly Allott0Walid Yassin1Luis Alameda2Tashrif Billah3Owen Borders4Kate Buccilli5Ricardo E. Carrión6Rolando I. Castillo-Passi7Kang Ik K. Cho8Kota Chin9Michael J. Coleman10Beau-Luke Colton11Sebastián Corral12Dominic Dwyer13Kristina Ballestad Gundersen14Ruben C. Gur15Gil D. Hoftman16Grace R. Jacobs17Sinead Kelly18Kathryn E. Lewandowski19Patricia J. Marcy20Priya Matneja21Danielle McLaughlin22Angela R. Nunez23Setari Parsa24Nora Penzel25Susan Ray26Jenna M. Reinen27Kosha Ruparel28Michael S. Sand29Gennarina Santorelli30Johanna Seitz-Holland31Jessica Spark32Zailyn Tamayo33Andrew Thompson34Sophie Tod35Cassandra M. J. Wannan36Alana Wickham37Stephen J. Wood38Eirini Zoupou39Jean Addington40Alan Anticevic41Celso Arango42Nicholas J. K. Breitborde43Matthew R. Broome44Kristin S. Cadenhead45Monica E. Calkins46Eric Yu Hai Chen47Jimmy Choi48Philippe Conus49Cheryl M. Corcoran50Barbara A. Cornblatt51Lauren M. Ellman52Paolo Fusar-Poli53Pablo A. Gaspar54Carla Gerber55Louise Birkedal Glenthøj56Leslie E. Horton57Christy Lai Ming Hui58Joseph Kambeitz59Lana Kambeitz-Ilankovic60Matcheri Keshavan61Sung-Wan Kim62Nikolaos Koutsouleris63Jun Soo Kwon64Kerstin Langbein65Daniel Mamah66Covadonga M. Diaz-Caneja67Daniel H. Mathalon68Vijay A. Mittal69Merete Nordentoft70Godfrey D. Pearlson71Diana O. Perkins72Jesus Perez73Albert R. Powers74Jack Rogers75Fred W. Sabb76Jason Schiffman77Jai L. Shah78Steven M. Silverstein79Stefan Smesny80Gregory P. Strauss81Judy L. Thompson82Rachel Upthegrove83Swapna K. Verma84Jijun Wang85Daniel H. Wolf86Ofer Pasternak87Sylvain Bouix88Patrick D. McGorry89John M. Kane90Rene S. Kahn91Carrie E. Bearden92Martha E. Shenton93Scott W. Woods94Barnaby Nelson95Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ)William S. Stone96OrygenDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical SchoolGeneral Psychiatry Service, Treatment and Early Intervention in Psychosis Program (TIPP–Lausanne), Lausanne University Hospital and University of LausanneDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolOrygenDepartment of Psychiatry, Donald and Barbara Zucker School of MedicineDepartment of Psychiatry, IMHAY, University of ChileDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolOrygenDepartment of Psychiatry, University of ChileOrygenVIRTU Research Group, Copenhagen Research Centre for Mental Health, Mental Health Copenhagen, University of CopenhagenDepartment of Psychiatry, Perelman School of Medicine, University of PennsylvaniaNorthwell HealthDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolPsychotic Disorders Division, McLean HospitalNorthwell HealthNorthwell HealthNorthwell HealthDepartment of Psychiatry, Yale University School of MedicineDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical SchoolDepartment of Psychiatry, Massachusetts General Hospital and Harvard Medical SchoolNorthwell HealthIBM ResearchDepartment of Psychiatry, Perelman School of Medicine, University of PennsylvaniaS2 Consulting LLCDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical SchoolDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolOrygenDepartment of Psychiatry, Yale University School of MedicineOrygenOrygenOrygenDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolOrygenDepartment of Psychiatry, Perelman School of Medicine, University of PennsylvaniaDepartment of Psychiatry, Hotchkiss Brain Institute, University of CalgaryDepartment of Psychiatry, Yale University School of MedicineDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, ISCIII, School of Medicine, Universidad ComplutenseDepartment of Psychiatry and Behavioral Health, Ohio State UniversityInstitute for Mental Health, School of Psychology, University of BirminghamUniversity of CaliforniaDepartment of Psychiatry, Perelman School of Medicine, University of PennsylvaniaDepartment of Psychiatry, School of Clinical Medicine, LKF Faculty of Medicine, University of Hong KongOlin Neuropsychiatry Research Center, Hartford Health Care Behavioral Health NetworkGeneral Psychiatry Service, Treatment and Early Intervention in Psychosis Program (TIPP–Lausanne), Lausanne University Hospital and University of LausanneDepartment of Psychiatry, Icahn School of Medicine at Mount SinaiDepartment of Psychiatry, Donald and Barbara Zucker School of MedicineDepartment of Psychology & Neuroscience, Temple UniversityDepartment of Psychosis Studies, King’s College LondonInstitute of Behavioral Science, Feinstein Institute for Medical ResearchPrevention Science Institute, University of OregonVIRTU Research Group, Copenhagen Research Centre for Mental Health, Mental Health Copenhagen, University of CopenhagenDepartment of Psychiatry, University of Pittsburgh School of MedicineDepartment of Psychiatry, School of Clinical Medicine, LKF Faculty of Medicine, University of Hong KongUniversity of Cologne, Faculty of Medicine and University HospitalCologneUniversity of Cologne, Faculty of Medicine and University HospitalCologneDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical SchoolDepartment of Psychiatry, Chonnam National University Medical SchoolDepartment of Psychosis Studies, King’s College LondonDepartment of Psychiatry, Seoul National University College of MedicineDepartment of Psychiatry and Psychotherapy, Jena University HospitalDepartment of Psychiatry, Washington University School of MedicineDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), CIBERSAM, ISCIII, School of Medicine, Universidad ComplutenseDepartment of Psychiatry and Behavioral Sciences and Weill Institute for Neurosciences, University of California, San FranciscoDepartment of Psychology, Northwestern UniversityCopenhagen Research Centre for Mental Health, Mental Health Copenhagen, University of CopenhagenOlin Neuropsychiatry Research Center, Institute of Living, Hartford HospitalDepartment of Psychiatry, University of North CarolinaCAMEO, Early Intervention in Psychosis Service, Cambridgeshire and Peterborough NHS Foundation TrustConnecticut Mental Health CenterInstitute for Mental Health, School of Psychology, University of BirminghamPrevention Science Institute, University of OregonDepartment of Psychological Science, University of CaliforniaPEPP-Montreal, Douglas Research CentreDepartment of Psychiatry, University of Rochester Medical CenterDepartment of Psychiatry and Psychotherapy, Jena University HospitalDepartment of Psychology, University of GeorgiaDepartment of Psychiatry, University of Rochester Medical CenterInstitute for Mental Health, School of Psychology, University of BirminghamInstitute of Mental HealthShanghai Mental Health Center, Shanghai Jiaotong University School of MedicineDepartment of Psychiatry, Perelman School of Medicine, University of PennsylvaniaDepartment of Psychiatry, Brigham and Women’s Hospital, Harvard Medical SchoolDepartment of Software Engineering and Information Technology, Ecole de technologie superieureOrygenDepartment of Psychiatry, Donald and Barbara Zucker School of MedicineDepartment of Psychiatry, Icahn School of Medicine at Mount SinaiDepartments of Psychiatry and Biobehavioral Sciences & Psychology, Semel Institute for Neuroscience and Human Behavior, University of CaliforniaDepartments of Psychiatry and Radiology, Brigham and Women’s Hospital, and Massachusetts General Hospital, Harvard Medical SchoolConnecticut Mental Health CenterOrygenDepartment of Psychiatry, Beth Israel Deaconess Medical Center, Massachusetts Mental Health Center and Harvard Medical SchoolAbstract Cognitive impairment occurs at higher rates in individuals at clinical high risk (CHR) for psychosis relative to healthy peers, and it contributes unique variance to multivariate prediction models of transition to psychosis. Such impairment is considered a core biomarker of schizophrenia. Thus, cognition is a key domain measured in the Accelerating Medicines Partnership® program for Schizophrenia (AMP SCZ initiative). The aim of this paper is to describe the rationale, processes, considerations, and final harmonization of the cognitive battery used in AMP SCZ across the two data collection networks. This battery comprises tests of general intellect and specific cognitive domains. We estimate premorbid intelligence at baseline and measure current intelligence at baseline and 2 years. Eight tests from the Penn Computerized Neurocognitive Battery (PennCNB), which measure verbal learning and memory, sensorimotor ability, attention, emotion recognition, working memory, processing speed, verbal memory, visual memory, and motor speed are administered repeatedly at baseline, and four follow-up timepoints over 2 years. Watch Dr. Kelly Allott and Dr. William S. Stone discuss their work and this article: https://vimeo.com/1023396087 .https://doi.org/10.1038/s41537-025-00578-1 |
| spellingShingle | Kelly Allott Walid Yassin Luis Alameda Tashrif Billah Owen Borders Kate Buccilli Ricardo E. Carrión Rolando I. Castillo-Passi Kang Ik K. Cho Kota Chin Michael J. Coleman Beau-Luke Colton Sebastián Corral Dominic Dwyer Kristina Ballestad Gundersen Ruben C. Gur Gil D. Hoftman Grace R. Jacobs Sinead Kelly Kathryn E. Lewandowski Patricia J. Marcy Priya Matneja Danielle McLaughlin Angela R. Nunez Setari Parsa Nora Penzel Susan Ray Jenna M. Reinen Kosha Ruparel Michael S. Sand Gennarina Santorelli Johanna Seitz-Holland Jessica Spark Zailyn Tamayo Andrew Thompson Sophie Tod Cassandra M. J. Wannan Alana Wickham Stephen J. Wood Eirini Zoupou Jean Addington Alan Anticevic Celso Arango Nicholas J. K. Breitborde Matthew R. Broome Kristin S. Cadenhead Monica E. Calkins Eric Yu Hai Chen Jimmy Choi Philippe Conus Cheryl M. Corcoran Barbara A. Cornblatt Lauren M. Ellman Paolo Fusar-Poli Pablo A. Gaspar Carla Gerber Louise Birkedal Glenthøj Leslie E. Horton Christy Lai Ming Hui Joseph Kambeitz Lana Kambeitz-Ilankovic Matcheri Keshavan Sung-Wan Kim Nikolaos Koutsouleris Jun Soo Kwon Kerstin Langbein Daniel Mamah Covadonga M. Diaz-Caneja Daniel H. Mathalon Vijay A. Mittal Merete Nordentoft Godfrey D. Pearlson Diana O. Perkins Jesus Perez Albert R. Powers Jack Rogers Fred W. Sabb Jason Schiffman Jai L. Shah Steven M. Silverstein Stefan Smesny Gregory P. Strauss Judy L. Thompson Rachel Upthegrove Swapna K. Verma Jijun Wang Daniel H. Wolf Ofer Pasternak Sylvain Bouix Patrick D. McGorry John M. Kane Rene S. Kahn Carrie E. Bearden Martha E. Shenton Scott W. Woods Barnaby Nelson Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) William S. Stone Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample Schizophrenia |
| title | Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample |
| title_full | Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample |
| title_fullStr | Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample |
| title_full_unstemmed | Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample |
| title_short | Cognitive assessment in the Accelerating Medicines Partnership® Schizophrenia Program: harmonization priorities and strategies in a diverse international sample |
| title_sort | cognitive assessment in the accelerating medicines partnership r schizophrenia program harmonization priorities and strategies in a diverse international sample |
| url | https://doi.org/10.1038/s41537-025-00578-1 |
| work_keys_str_mv | AT kellyallott cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT walidyassin cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT luisalameda cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT tashrifbillah cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT owenborders cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT katebuccilli cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT ricardoecarrion cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT rolandoicastillopassi cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kangikkcho cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kotachin cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT michaeljcoleman cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT beaulukecolton cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT sebastiancorral cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT dominicdwyer cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kristinaballestadgundersen cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT rubencgur cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT gildhoftman cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT gracerjacobs cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT sineadkelly cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kathrynelewandowski cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT patriciajmarcy cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT priyamatneja cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT daniellemclaughlin cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT angelarnunez cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT setariparsa cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT norapenzel cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT susanray cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jennamreinen cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kosharuparel cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT michaelssand cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT gennarinasantorelli cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT johannaseitzholland cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jessicaspark cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT zailyntamayo cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT andrewthompson cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT sophietod cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT cassandramjwannan cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT alanawickham cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT stephenjwood cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT eirinizoupou cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jeanaddington cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT alananticevic cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT celsoarango cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT nicholasjkbreitborde cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT matthewrbroome cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kristinscadenhead cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT monicaecalkins cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT ericyuhaichen cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jimmychoi cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT philippeconus cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT cherylmcorcoran cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT barbaraacornblatt cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT laurenmellman cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT paolofusarpoli cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT pabloagaspar cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT carlagerber cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT louisebirkedalglenthøj cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT leslieehorton cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT christylaiminghui cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT josephkambeitz cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT lanakambeitzilankovic cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT matcherikeshavan cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT sungwankim cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT nikolaoskoutsouleris cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT junsookwon cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT kerstinlangbein cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT danielmamah cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT covadongamdiazcaneja cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT danielhmathalon cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT vijayamittal cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT meretenordentoft cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT godfreydpearlson cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT dianaoperkins cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jesusperez cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT albertrpowers cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jackrogers cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT fredwsabb cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jasonschiffman cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jailshah cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT stevenmsilverstein cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT stefansmesny cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT gregorypstrauss cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT judylthompson cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT rachelupthegrove cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT swapnakverma cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT jijunwang cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT danielhwolf cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT oferpasternak cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT sylvainbouix cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT patrickdmcgorry cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT johnmkane cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT reneskahn cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT carrieebearden cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT marthaeshenton cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT scottwwoods cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT barnabynelson cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT acceleratingmedicinespartnershipschizophreniaampscz cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample AT williamsstone cognitiveassessmentintheacceleratingmedicinespartnershipschizophreniaprogramharmonizationprioritiesandstrategiesinadiverseinternationalsample |